COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine
Sign Up to like & getrecommendations! Published in 2020 at "Virologica Sinica"
DOI: 10.1007/s12250-020-00297-0
Abstract: The World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) is the first pandemic caused by coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there is no effective anti-SARS-CoV-2 drug approved worldwide… read more here.
Keywords: medicine; traditional chinese; antiviral agents; antibody development ... See more keywords
327: DOCUMENTING THE TIMING AND KEY FACTORS IN POST-VACCINATION SARS-COV-2 HUMORAL ANTIBODY DEVELOPMENT
Sign Up to like & getrecommendations! Published in 2021 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000807632.65265.89
Abstract: B Introduction: b The study purpose was to observe the relative timing of humoral (IgM, IgG) antibody (Ab) development following SARS-CoV2 mRNA vaccination and identify associated factors. B Conclusions: b Age and immunomodulating conditions/therapies impact… read more here.
Keywords: vaccination; timing; medicine; antibody development ... See more keywords
Abstract 5658: A homogenous PBMC ADCC bioassay enables bridging studies with ADCC reporter bioassays in immunotherapy monoclonal antibody development
Sign Up to like & getrecommendations! Published in 2020 at "Immunology"
DOI: 10.1158/1538-7445.am2020-5658
Abstract: Measurement of antibody-dependent cellular cytotoxicity (ADCC) is critical for characterizing antibody Fc effector functions during monoclonal antibody development. Classic ADCC assays measure the short-term cytotoxicity of target cells, typically pre-loaded with radioactive or fluorescent dyes,… read more here.
Keywords: antibody development; adcc reporter; antibody; monoclonal antibody ... See more keywords